These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1851683)

  • 1. Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea.
    Krieger J; Follenius M; Sforza E; Brandenberger G; Peter JD
    Clin Sci (Lond); 1991 May; 80(5):443-9. PubMed ID: 1851683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure.
    Krieger J; Laks L; Wilcox I; Grunstein RR; Costas LJ; McDougall JG; Sullivan CE
    Clin Sci (Lond); 1989 Oct; 77(4):407-11. PubMed ID: 2530023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure.
    Kita H; Ohi M; Chin K; Noguchi T; Otsuka N; Tsuboi T; Itoh H; Nakao K; Kuno K
    J Sleep Res; 1998 Sep; 7(3):199-207. PubMed ID: 9785275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of guanosine 3':5'-cyclic monophosphate during sleep in obstructive sleep apnoea patients with and without nasal continuous positive airway pressure treatment.
    Krieger J; Schmidt M; Sforza E; Lehr L; Imbs JL; Coumaros G; Kurtz D
    Clin Sci (Lond); 1989 Jan; 76(1):31-7. PubMed ID: 2537703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal continuous positive airway pressure with supplemental oxygen in coexistent sleep apnoea-hypopnoea syndrome and severe chronic obstructive pulmonary disease.
    Sampol G; Sagalés MT; Roca A; de la Calzada MD; Bofill JM; Morell F
    Eur Respir J; 1996 Jan; 9(1):111-6. PubMed ID: 8834343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide levels and pulmonary artery pressure awake, at exercise and asleep in obstructive sleep apnoea syndrome.
    Schäfer H; Ehlenz K; Ewig S; Hasper E; Koehler U; Latzelsberger J; Tasci S; Lüderitz B
    J Sleep Res; 1999 Sep; 8(3):205-10. PubMed ID: 10476007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome.
    Baruzzi A; Riva R; Cirignotta F; Zucconi M; Cappelli M; Lugaresi E
    Sleep; 1991 Feb; 14(1):83-6. PubMed ID: 1839810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic peptide levels in the sleep apnoea/hypopnoea syndrome.
    Mackay TW; Fitzpatrick MF; Freestone S; Lee MR; Douglas NJ
    Thorax; 1994 Sep; 49(9):920-1. PubMed ID: 7940435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of atrial natriuretic factor in moderate to severe obstructive sleep apnea syndrome.
    Lin CC; Tsan KW; Lin CY
    Sleep; 1993 Jan; 16(1):37-9. PubMed ID: 8456234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma brain natriuretic peptide in obstructive sleep apnea.
    Svatikova A; Shamsuzzaman AS; Wolk R; Phillips BG; Olson LJ; Somers VK
    Am J Cardiol; 2004 Aug; 94(4):529-32. PubMed ID: 15325948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased nocturnal sodium excretion in obstructive sleep apnoea. Relation to nocturnal change in diastolic blood pressure.
    Gjørup PH; Sadauskiene L; Wessels J; Nyvad O; Strunge B; Pedersen EB
    Scand J Clin Lab Invest; 2008; 68(1):11-21. PubMed ID: 18224555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory blood pressure and left ventricular hypertrophy in subjects with untreated obstructive sleep apnoea and snoring, compared with matched control subjects, and their response to treatment.
    Davies RJ; Crosby J; Prothero A; Stradling JR
    Clin Sci (Lond); 1994 Apr; 86(4):417-24. PubMed ID: 8168336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal, haemodynamic and hormonal interactions between atrial natriuretic factor and arginine vasopressin in patients with congestive heart failure.
    Nakamura M; Yoshida H; Funakoshi T; Arakawa N; Hiramori K
    Clin Sci (Lond); 1992 Apr; 82(4):363-8. PubMed ID: 1315645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of plasma volume during obstructive sleep apnoea.
    Krieger J
    J Sleep Res; 1995 Jun; 4(S1):107-111. PubMed ID: 10607185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous positive airway pressure treatment. Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients.
    Saini J; Krieger J; Brandenberger G; Wittersheim G; Simon C; Follenius M
    Horm Metab Res; 1993 Jul; 25(7):375-81. PubMed ID: 8406324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Home treatment of obstructive sleep apnoea with continuous positive airway pressure applied through a nose-mask.
    Sullivan CE; Issa FG; Berthon-Jones M; McCauley VB; Costas LJ
    Bull Eur Physiopathol Respir; 1984; 20(1):49-54. PubMed ID: 6367865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal control of sodium and water excretion in obstructive sleep apnoea.
    Krieger J
    Scand J Urol Nephrol Suppl; 1995; 173():65-8; discussion 68-9. PubMed ID: 8719571
    [No Abstract]   [Full Text] [Related]  

  • 18. A possible role of atrial natriuretic peptide in ethanol-induced acute diuresis.
    Colantonio D; Casale R; Desiati P; De Michele G; Mammarella M; Pasqualetti P
    Life Sci; 1991; 48(7):635-42. PubMed ID: 1824957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nasal CPAP treatment on plasma volume, aldosterone and 24-h blood pressure in obstructive sleep apnoea.
    Saarelainen S; Hasan J; Siitonen S; Seppälä E
    J Sleep Res; 1996 Sep; 5(3):181-5. PubMed ID: 8956208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive hydration during continuous positive-pressure ventilation restores atrial transmural pressure, plasma atrial natriuretic peptide concentrations, and renal function.
    Ramamoorthy C; Rooney MW; Dries DJ; Mathru M
    Crit Care Med; 1992 Jul; 20(7):1014-9. PubMed ID: 1535581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.